Tevogen Bio Holdings 评估收购 Sciometrix 及 Clinicus 平台以监测长期新冠症状

美股速递
Mar 12

Tevogen Bio Holdings Inc. 正在考虑收购 Sciometrix 和 Clinicus 平台,旨在加强对长期新冠(Long Covid)的监测能力。此举显示该公司正积极拓展其在生物科技领域的布局,特别是在应对新冠后遗症方面寻求新的解决方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10